San Francisco, California, United States
Contact Info
5K followers
500+ connections
San Francisco, California, United States
Contact Info
5K followers
500+ connections
Activity
-
I'm proud to announce that our portfolio company EyeBio has been acquired by Merck for $1.3B upfront and up to $3B, just 7 months after our…
I'm proud to announce that our portfolio company EyeBio has been acquired by Merck for $1.3B upfront and up to $3B, just 7 months after our…
Liked by Amit Sinha
-
A walk down memory lane: It is important to cherish the path that led us to the present. For me, going back to Indian Institute of Technology, Madras…
A walk down memory lane: It is important to cherish the path that led us to the present. For me, going back to Indian Institute of Technology, Madras…
Liked by Amit Sinha
-
“Resist the idea that anything you’ve done here at Stanford has already locked you into one path or any one kind of life or career. Remember that…
“Resist the idea that anything you’ve done here at Stanford has already locked you into one path or any one kind of life or career. Remember that…
Liked by Amit Sinha
Experience & Education
More activity by Amit
-
I'm proud of my team at Foresite Capital on this milestone. Our thesis has remained remarkably consistent since our inception in 2011, when we…
I'm proud of my team at Foresite Capital on this milestone. Our thesis has remained remarkably consistent since our inception in 2011, when we…
Liked by Amit Sinha
-
Last week, I had the distinct honor of speaking at and serving as a co-chair with Brett Hart and Tony Goldwyn for the Innocence Project’s annual…
Last week, I had the distinct honor of speaking at and serving as a co-chair with Brett Hart and Tony Goldwyn for the Innocence Project’s annual…
Liked by Amit Sinha
-
Ajax Therapeutics Announces FDA Clearance of IND Application for AJ1-11095, a First-in-Class Type II JAK2 inhibitor, for the Treatment of…
Ajax Therapeutics Announces FDA Clearance of IND Application for AJ1-11095, a First-in-Class Type II JAK2 inhibitor, for the Treatment of…
Liked by Amit Sinha
-
We are excited to partner with the Ajax Therapeutics team and support the company in developing a first-in-class Type II JAK2 inhibitor to treat…
We are excited to partner with the Ajax Therapeutics team and support the company in developing a first-in-class Type II JAK2 inhibitor to treat…
Liked by Amit Sinha
-
In the past week, we are pleased to have led two financings for exciting companies working on novel treatments for blood cancers and inflammatory…
In the past week, we are pleased to have led two financings for exciting companies working on novel treatments for blood cancers and inflammatory…
Shared by Amit Sinha
-
Congratulations to Alterome on their successful Series B financing! We are proud to have led the financing and partner with the Company to advance…
Congratulations to Alterome on their successful Series B financing! We are proud to have led the financing and partner with the Company to advance…
Shared by Amit Sinha
-
Today, we announce the appointment of three members to our board of directors. “Anna, John and Tom each brings a diversified skillset spanning…
Today, we announce the appointment of three members to our board of directors. “Anna, John and Tom each brings a diversified skillset spanning…
Liked by Amit Sinha
-
BPGbio Appoints Ritesh Srivastava as General Counsel - https://lnkd.in/g5pXSk8m Follow #citybiz on LinkedIn - https://lnkd.in/eBgXKiz8 Ritesh…
BPGbio Appoints Ritesh Srivastava as General Counsel - https://lnkd.in/g5pXSk8m Follow #citybiz on LinkedIn - https://lnkd.in/eBgXKiz8 Ritesh…
Liked by Amit Sinha
-
A unique experience to visit the remotest continent, #Antarctica, on invitation from #CongresoFuturo organized by the Chilean Senate. Everything was…
A unique experience to visit the remotest continent, #Antarctica, on invitation from #CongresoFuturo organized by the Chilean Senate. Everything was…
Liked by Amit Sinha
-
We're thrilled to announce that Ritesh Srivastava is joining BPGbio as our new General Counsel! “His extensive experience serving as a business…
We're thrilled to announce that Ritesh Srivastava is joining BPGbio as our new General Counsel! “His extensive experience serving as a business…
Liked by Amit Sinha
-
Great experience partnering with Amit Sinha , Johanna Diaz and Rachel Rattner to help build a phenomenal team. Excited to watch Amit Sinha, Colin…
Great experience partnering with Amit Sinha , Johanna Diaz and Rachel Rattner to help build a phenomenal team. Excited to watch Amit Sinha, Colin…
Liked by Amit Sinha
-
We announced a new $650M fund today, Venrock 10. We expect Venrock 10’s portfolio to build very similarly to recent efforts – mostly seed/series A…
We announced a new $650M fund today, Venrock 10. We expect Venrock 10’s portfolio to build very similarly to recent efforts – mostly seed/series A…
Liked by Amit Sinha
-
TCGX is delighted to announce the closing of a $1B oversubscribed Fund II! We look forward to partnering with incredible private and public biotech…
TCGX is delighted to announce the closing of a $1B oversubscribed Fund II! We look forward to partnering with incredible private and public biotech…
Liked by Amit Sinha
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Amit Sinha in United States
85 others named Amit Sinha in United States are on LinkedIn
See others named Amit Sinha